It is the low plasma concentrations of TRAIL in this group of patients that are associated with a higher risk of CV mortality, a higher risk of post-infarction left ventricular remodelling and the development of HF [6, 34, 73, 76–78]. The gene discussed is TNFSF10; the disease is hydrops fetalis.